Frank Lamberti Sells 7,937 Shares of Herbalife (NYSE:HLF) Stock

Herbalife Ltd (NYSE:HLF) insider Frank Lamberti sold 7,937 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $13.86, for a total value of $110,006.82. Following the sale, the insider directly owned 171,606 shares of the company’s stock, valued at approximately $2,378,459.16. This represents a 4.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Frank Lamberti also recently made the following trade(s):

• On Tuesday, May 12th, Frank Lamberti sold 134,982 shares of Herbalife stock. The stock was sold at an average price of $13.50, for a total value of $1,822,257.00.

Herbalife Price Performance

Shares of NYSE HLF opened at $13.05 on Friday. The stock has a fifty day moving average price of $15.36 and a 200 day moving average price of $14.45. Herbalife Ltd has a 1-year low of $6.63 and a 1-year high of $20.40. The company has a market cap of $1.35 billion, a PE ratio of 5.72, a P/E/G ratio of 0.77 and a beta of 0.98.

Herbalife (NYSE:HLF) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.30 billion. During the same period last year, the company earned $0.59 earnings per share. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Analysts anticipate that Herbalife Ltd will post 2.47 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Optimize Financial Inc purchased a new position in shares of Herbalife in the third quarter valued at $511,000. GSA Capital Partners LLP purchased a new position in shares of Herbalife in the third quarter valued at $911,000. CenterBook Partners LP purchased a new position in shares of Herbalife in the third quarter valued at $368,000. Picton Mahoney Asset Management purchased a new position in shares of Herbalife in the third quarter valued at $898,000. Finally, Hussman Strategic Advisors Inc. purchased a new position in shares of Herbalife in the third quarter valued at $532,000.

Wall Street Analyst Weigh In

HLF has been the subject of a number of recent analyst reports. Zacks Research downgraded Herbalife from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Citigroup reissued a “buy” rating and issued a $21.00 target price (up from $17.00) on shares of Herbalife in a report on Thursday, February 19th. Mizuho set a $17.00 target price on Herbalife in a report on Monday, May 4th. Royal Bank Of Canada reduced their target price on Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a report on Tuesday, April 28th. Finally, Wall Street Zen raised Herbalife from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 18th. Three equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $17.80.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.